The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
Mitochondria and cancer chemoresistance
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
Fundamentals of Cancer Metabolism
DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013
Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy
Wallace, D. C., Singh, G., Lott, M. T., Hodge, J. A., Schurr, T. G., Lezza, A. M. S., Elsas, L. J., & Nikoskelainen, E. K. (1988) · Science · doi:10.1126/science.3201231 · Cited by 2,440
Vyas, S., Zaganjor, E., & Haigis, M. C. (2016) · Cell · doi:10.1016/j.cell.2016.07.002 · Cited by 1,735
Targeting mitochondria for cancer therapy
Fulda, S., Galluzzi, L., & Kroemer, G. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3137 · Cited by 1,629
Human Cells Lacking mtDNA: Repopulation with Exogenous Mitochondria by Complementation
King, M. P., & Attardi, G. (1989) · Science · doi:10.1126/science.2814477 · Cited by 1,611
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis
Melo, S. A., Sugimoto, H., O’Connell, J. T., Kato, N., Villanueva, A., Vidal, A., Qiu, L., Vitkin, E., Perelman, L. T., Melo, C. A., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.005 · Cited by 1,531
ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis
Ishikawa, K., Takenaga, K., Akimoto, M., Koshikawa, N., Yamaguchi, A., Imanishi, H., Nakada, K., Honma, Y., & Hayashi, J.-I. (2008) · Science · doi:10.1126/science.1156906 · Cited by 1,444
Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation
(1990) · Trends in Genetics · doi:10.1016/0168-9525(90)90040-d · Cited by 1,387
Glutamine and cancer: cell biology, physiology, and clinical opportunities
Hensley, C. T., Wasti, A. T., & DeBerardinis, R. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69600 · Cited by 1,262
Roesch, A., Fukunaga-Kalabis, M., Schmidt, E. C., Zabierowski, S. E., Brafford, P. A., Vultur, A., Basu, D., Gimotty, P., Vogt, T., & Herlyn, M. (2010) · Cell · doi:10.1016/j.cell.2010.04.020 · Cited by 1,158
Mitochondrial transfer between cells can rescue aerobic respiration
Spees, J. L., Olson, S. D., Whitney, M. J., & Prockop, D. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510511103 · Cited by 1,137
Hirayama, A., Kami, K., Sugimoto, M., Sugawara, M., Toki, N., Onozuka, H., Kinoshita, T., Saito, N., Ochiai, A., Tomita, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4806 · Cited by 956
Butow, R. A., & Avadhani, N. G. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00179-0 · Cited by 882
Tan, A. S., Baty, J. W., Dong, L.-F., Bezawork-Geleta, A., Endaya, B., Goodwin, J., Bajzikova, M., Kovarova, J., Peterka, M., Yan, B., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.003 · Cited by 785
Cancer stem cells: The challenges ahead
Medema, J. P. (2013) · Nature Cell Biology · doi:10.1038/ncb2717 · Cited by 741
MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells
Sancho, P., Burgos-Ramos, E., Tavera, A., Bou Kheir, T., Jagust, P., Schoenhals, M., Barneda, D., Sellers, K., Campos-Olivas, R., Graña, O., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.08.015 · Cited by 722
Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
Birsoy, K., Possemato, R., Lorbeer, F. K., Bayraktar, E. C., Thiru, P., Yucel, B., Wang, T., Chen, W. W., Clish, C. B., & Sabatini, D. M. (2014) · Nature · doi:10.1038/nature13110 · Cited by 710
Roesch, A., Vultur, A., Bogeski, I., Wang, H., Zimmermann, K. M., Speicher, D., Körbel, C., Laschke, M. W., Gimotty, P. A., Philipp, S. E., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.05.003 · Cited by 670
Astrocytes and Glioblastoma cells release exosomes carrying mtDNA
Guescini, M., Genedani, S., Stocchi, V., & Agnati, L. F. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-009-0288-8 · Cited by 661
Hallmarks of cancer stem cell metabolism
Sancho, P., Barneda, D., & Heeschen, C. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.152 · Cited by 574
A Mitochondrial Switch Promotes Tumor Metastasis
Porporato, P. E., Payen, V. L., Pérez-Escuredo, J., De Saedeleer, C. J., Danhier, P., Copetti, T., Dhup, S., Tardy, M., Vazeille, T., Bouzin, C., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.043 · Cited by 571
Transfer of mitochondria via tunneling nanotubes rescues apoptotic PC12 cells
Wang, X., & Gerdes, H.-H. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.211 · Cited by 527
Pasquier, J., Guerrouahen, B. S., Al Thawadi, H., Ghiabi, P., Maleki, M., Abu-Kaoud, N., Jacob, A., Mirshahi, M., Galas, L., Rafii, S., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-94 · Cited by 502
Moschoi, R., Imbert, V., Nebout, M., Chiche, J., Mary, D., Prebet, T., Saland, E., Castellano, R., Pouyet, L., Collette, Y., et al. (2016) · Blood · doi:10.1182/blood-2015-07-655860 · Cited by 463
2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy
Zhang, D., Li, J., Wang, F., Hu, J., Wang, S., & Sun, Y. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.09.003 · Cited by 462
Glutaminolysis as a target for cancer therapy
Jin, L., Alesi, G. N., & Kang, S. (2016) · Oncogene · doi:10.1038/onc.2015.447 · Cited by 459
Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression
Santidrian, A. F., Matsuno-Yagi, A., Ritland, M., Seo, B. B., LeBoeuf, S. E., Gay, L. J., Yagi, T., & Felding-Habermann, B. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64264 · Cited by 433
Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs
Bacman, S. R., Williams, S. L., Pinto, M., Peralta, S., & Moraes, C. T. (2013) · Nature Medicine · doi:10.1038/nm.3261 · Cited by 432
Clem, B., Telang, S., Clem, A., Yalcin, A., Meier, J., Simmons, A., Rasku, M. A., Arumugam, S., Dean, W. L., Eaton, J., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0482 · Cited by 432
Ye, J., Mancuso, A., Tong, X., Ward, P. S., Fan, J., Rabinowitz, J. D., & Thompson, C. B. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204176109 · Cited by 410
Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis
Xiang, Y., Stine, Z. E., Xia, J., Lu, Y., O’Connor, R. S., Altman, B. J., Hsieh, A. L., Gouw, A. M., Thomas, A. G., Gao, P., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci75836 · Cited by 409
Pelicano, H., Xu, R.-H., Du, M., Feng, L., Sasaki, R., Carew, J. S., Hu, Y., Ramdas, L., Hu, L., Keating, M. J., et al. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200512100 · Cited by 387
Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer
Wu, C., Yin, P., Hung, W., Li, A. F., Li, S., Chi, C., Wei, Y., & Lee, H. (2005) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20213 · Cited by 381
Glutamine transporters in mammalian cells and their functions in physiology and cancer
Bhutia, Y. D., & Ganapathy, V. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.12.017 · Cited by 325
Gasparre, G., Porcelli, A. M., Bonora, E., Pennisi, L. F., Toller, M., Iommarini, L., Ghelli, A., Moretti, M., Betts, C. M., Martinelli, G. N., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703056104 · Cited by 316
Gene Recombination in the Bacterium Escherichia coli
Tatum, E. L., & Lederberg, J. (1947) · Journal of Bacteriology · doi:10.1128/jb.53.6.673-684.1947 · Cited by 315
Connecting Mitochondria, Metabolism, and Stem Cell Fate
Wanet, A., Arnould, T., Najimi, M., & Renard, P. (2015) · Stem Cells and Development · doi:10.1089/scd.2015.0117 · Cited by 313
Role of mitochondrial dysfunction in cancer progression
Hsu, C.-C., Tseng, L.-M., & Lee, H.-C. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216641787 · Cited by 305
Poly(ADP-ribose) polymerase (PARP-1) has a controlling role in homologous recombination
Schultz, N. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg703 · Cited by 301
Gammage, P. A., Rorbach, J., Vincent, A. I., Rebar, E. J., & Minczuk, M. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201303672 · Cited by 299
The tumor microenvironment and metastatic disease
Lunt, S. J., Chaudary, N., & Hill, R. P. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9182-2 · Cited by 298
Shidara, Y., Yamagata, K., Kanamori, T., Nakano, K., Kwong, J. Q., Manfredi, G., Oda, H., & Ohta, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2012 · Cited by 286
Mitochondrial DNA replication during differentiation of murine embryonic stem cells
Facucho-Oliveira, J. M., Alderson, J., Spikings, E. C., Egginton, S., & St. John, J. C. (2007) · Journal of Cell Science · doi:10.1242/jcs.016972 · Cited by 277
Mitochondrial Genome Instability and mtDNA Depletion in Human Cancers
LEE, H., YIN, P., LIN, J., WU, C., CHEN, C., WU, C., CHI, C., TAM, T., & WEI, Y. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1338.011 · Cited by 273
Shanmugam, M. K., Dai, X., Kumar, A. P., Tan, B. K. H., Sethi, G., & Bishayee, A. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.016 · Cited by 271
Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology
Sutendra, G., & Michelakis, E. D. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00038 · Cited by 262
Yu, M., Zhou, Y., Shi, Y., Ning, L., Yang, Y., Wei, X., Zhang, N., Hao, X., & Niu, R. (2007) · IUBMB Life · doi:10.1080/15216540701509955 · Cited by 250
Park, J. S., Sharma, L. K., Li, H., Xiang, R., Holstein, D., Wu, J., Lechleiter, J., Naylor, S. L., Deng, J. J., Lu, J., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp069 · Cited by 246
Walsh, C. S. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.02.017 · Cited by 245
Classification of mitocans, anti-cancer drugs acting on mitochondria
Neuzil, J., Dong, L.-F., Rohlena, J., Truksa, J., & Ralph, S. J. (2013) · Mitochondrion · doi:10.1016/j.mito.2012.07.112 · Cited by 245
Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer
Tseng, L., Yin, P., Chi, C., Hsu, C., Wu, C., Lee, L., Wei, Y., & Lee, H. (2006) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20326 · Cited by 244
The Warburg effect: Insights from the past decade
Upadhyay, M., Samal, J., Kandpal, M., Singh, O. V., & Vivekanandan, P. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.11.003 · Cited by 243
Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment
Tanaka, K., Sasayama, T., Irino, Y., Takata, K., Nagashima, H., Satoh, N., Kyotani, K., Mizowaki, T., Imahori, T., Ejima, Y., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78239 · Cited by 239
Bonora, E., Porcelli, A. M., Gasparre, G., Biondi, A., Ghelli, A., Carelli, V., Baracca, A., Tallini, G., Martinuzzi, A., Lenaz, G., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0171 · Cited by 225
Targeting glutamine transport to suppress melanoma cell growth
Wang, Q., Beaumont, K. A., Otte, N. J., Font, J., Bailey, C. G., van Geldermalsen, M., Sharp, D. M., Tiffen, J. C., Ryan, R. M., Jormakka, M., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28749 · Cited by 224
Guha, M., & Avadhani, N. G. (2013) · Mitochondrion · doi:10.1016/j.mito.2013.08.007 · Cited by 216
Assembly of mitochondrial complex I and defects in disease
Lazarou, M., Thorburn, D. R., Ryan, M. T., & McKenzie, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.04.015 · Cited by 212
Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions
Vernieri, C., Casola, S., Foiani, M., Pietrantonio, F., de Braud, F., & Longo, V. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0615 · Cited by 202
Hashimoto, M., Bacman, S. R., Peralta, S., Falk, M. J., Chomyn, A., Chan, D. C., Williams, S. L., & Moraes, C. T. (2015) · Molecular Therapy · doi:10.1038/mt.2015.126 · Cited by 199
Hudson, G., Keers, S., Man, P. Y. W., Griffiths, P., Huoponen, K., Savontaus, M.-L., Nikoskelainen, E., Zeviani, M., Carrara, F., Horvath, R., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/498176 · Cited by 194
Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes
Matre, P., Velez, J., Jacamo, R., Qi, Y., Su, X., Cai, T., Chan, S. M., Lodi, A., Sweeney, S. R., Ma, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12944 · Cited by 185
Mitochondrial complex I-linked disease
Rodenburg, R. J. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.02.012 · Cited by 183
Cho, Y. M., Kim, J. H., Kim, M., Park, S. J., Koh, S. H., Ahn, H. S., Kang, G. H., Lee, J.-B., Park, K. S., & Lee, H. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032778 · Cited by 173
Resistance of Mitochondrial DNA-depleted Cells against Cell Death
Park, S. Y., Chang, I., Kim, J.-Y., Kang, S. W., Park, S.-H., Singh, K., & Lee, M.-S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307677200 · Cited by 170
Sequence-specific modification of mitochondrial DNA using a chimeric zinc finger methylase
Minczuk, M., Papworth, M. A., Kolasinska, P., Murphy, M. P., & Klug, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609502103 · Cited by 166
Targeting SLC1a5‐mediated glutamine dependence in non‐small cell lung cancer
Hassanein, M., Qian, J., Hoeksema, M. D., Wang, J., Jacobovitz, M., Ji, X., Harris, F. T., Harris, B. K., Boyd, K. L., Chen, H., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29535 · Cited by 166
Lonidamine: Efficacy and safety in clinical trials for the treatment of solid tumors
Di Cosimo, S., Ferretti, G., Papaldo, P., Carlini, P., Fabi, A., & Cognetti, F. (2003) · Drugs of Today · doi:10.1358/dot.2003.39.3.799451 · Cited by 166
Sharma, L. K., Fang, H., Liu, J., Vartak, R. S., Deng, J., & Bai, Y. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr395 · Cited by 164
Green Tea Polyphenols Modulate Insulin Secretion by Inhibiting Glutamate Dehydrogenase
Li, C., Allen, A., Kwagh, J., Doliba, N. M., Qin, W., Najafi, H., Collins, H. W., Matschinsky, F. M., Stanley, C. A., & Smith, T. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512792200 · Cited by 163
Milane, L., Duan, Z., & Amiji, M. (2011) · Molecular Pharmaceutics · doi:10.1021/mp1002653 · Cited by 161
Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC
Stockwin, L. H., Yu, S. X., Borgel, S. D., Hancock, C. N., Wolfe, T. L., Phillips, L. R., Hollingshead, M. G., & Newton, D. L. (2010) · International Journal of Cancer · doi:10.1002/ijc.25499 · Cited by 161
Guha, M., Srinivasan, S., Ruthel, G. T., Kashina, A., Carstens, R. P., Mendoza, A., Khanna, C., Winkle, T. V., & Avadhani, N. G. (2013) · Oncogene · doi:10.1038/onc.2013.467 · Cited by 158
Gasparre, G., Hervouet, É., de Laplanche, E., Demont, J., Pennisi, L. F., Colombel, M. C., Mège‐Lechevallier, F., Scoazec, J., Bonora, E., Smeets, R., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm371 · Cited by 156
Hypersensitization of Tumor Cells to Glycolytic Inhibitors
Liu, H., Hu, Y., Savaraj, N., Priebe, W., & Lampidis, T. J. (2001) · Biochemistry · doi:10.1021/bi002426w · Cited by 148
Wanrooij, S., Goffart, S., Pohjoismäki, J. L. O., Yasukawa, T., & Spelbrink, J. N. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm215 · Cited by 148
Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target
Hur, H., Yi, X., Kim, Y. B., Lee, G., Shim, W., Yun, J., Ham, I., & Han, S. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1687 · Cited by 145
Lee, W., Johnson, J., Gough, D. J., Donoghue, J. F., Cagnone, G., Vaghjiani, V., Brown, K. A., Johns, T. G., & John, J. C. S. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.34 · Cited by 141
Obre, E., & Rossignol, R. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.12.008 · Cited by 137
Moro, L., Arbini, A., Yao, J., di Sant'Agnese, P. A., Marra, E., & Gréco, M. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.178 · Cited by 135
Self-citationVelpula, K. K., Bhasin, A., Asuthkar, S., & Tsung, A. J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1868 · Cited by 132
Decreased mitochondrial priming determines chemoresistance of colon cancer stem cells
Çolak, S., Zimberlin, C., Fessler, E., Hogdal, L. J., Prasetyanti, P. R., Grandela, C., Letai, A. G., & Medema, J. P. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.37 · Cited by 129
Learning from oncocytic tumors: Why choose inefficient mitochondria?
Gasparre, G., Romeo, G. C., Rugolo, M., & Porcelli, A. M. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.08.006 · Cited by 129
Milane, L. S., Ganesh, S., Shah, S., Duan, Z., & Amiji, M. M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.03.032 · Cited by 128
Yang, G. S., Chang, B., Yang, F., Guo, X. Q., Cai, K. Q., Xiao, X., Wang, H., Sen, S., Hung, M., Mills, G. B., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3171 · Cited by 128
Gilkerson, R., Margineantu, D. H., Capaldi, R., & Selker, J. M. L. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01527-1 · Cited by 124
Milane, L. S., Duan, Z., & Amiji, M. M. (2011) · Cancer Cell International · doi:10.1186/1475-2867-11-3 · Cited by 122
Milane, L. S., Duan, Z., & Amiji, M. M. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.12.009 · Cited by 119
The Metabolic Alterations of Cancer Cells
Sciacovelli, M., Gaude, E., Hilvo, M., & Frezza, C. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-416618-9.00001-7 · Cited by 116
Gasparre, G., Kurelac, I., Capristo, M., Iommarini, L., Ghelli, A. M., Ceccarelli, C., Nicoletti, G., Nanni, P., Giovanni, C. D., Scotlandi, K., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1042 · Cited by 109
(1994) · PubMed · Cited by 109
Variable clinical manifestation of homoplasmic G14459A mitochondrial DNA mutation
Gropman, A. L., Chen, T., Perng, C., Krasnewich, D. M., Chernoff, E., Tifft, C. J., & Wong, L. C. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20456 · Cited by 108
Milane, L. S., Duan, Z., & Amiji, M. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024075 · Cited by 102
Mitochondrial metabolism directs stemness and differentiation in P19 embryonal carcinoma stem cells
Vega‐Naredo, I., Loureiro, R., Mesquita, K. A., Barbosa, I. A., Tavares, L. C., Branco, A. F., Erickson, J. R., Holy, J. M., Perkins, E. L., Carvalho, R. A., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.66 · Cited by 100
Porcelli, A. M., Angelin, A., Ghelli, A. M., Mariani, E., Martinuzzi, A., Carelli, V., Petronilli, V., Bernardi, P., & Rugolo, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807321200 · Cited by 97
Carcinogenesis, cancer therapy and chemoprevention
Blagosklonny, M. V. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401610 · Cited by 91
Kloss‐Brandstätter, A., Schäfer, G., Erhart, G., Hüttenhofer, A., Coassin, S., Seifarth, C., Summerer, M., Bektić, J., Klocker, H., & Kronenberg, F. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.11.001 · Cited by 88
Mitochondrial dysfunction in cancer chemoresistance
Guaragnella, N., Giannattasio, S., & Moro, L. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.027 · Cited by 87
Self-citationMitochondrial DNA determines androgen dependence in prostate cancer cell lines
Higuchi, M., Kudo, T., Suzuki, S., Evans, T. T., Sasaki, R., Wada, Y., Shirakawa, T., Sawyer, J. R., & Gotoh, A. (2005) · Oncogene · doi:10.1038/sj.onc.1209190 · Cited by 86
Nath, K., NELSON, D. S., Heitjan, D. F., Leeper, D. B., Zhou, R., & Glickson, J. D. (2014) · NMR in Biomedicine · doi:10.1002/nbm.3240 · Cited by 85
The PGC-1α-dependent pathway of mitochondrial biogenesis is upregulated in type I endometrial cancer
Cormio, A., Guerra, F., Cormio, G., Pesce, V., Fracasso, F., Loizzi, V., Cantatore, P., Selvaggi, L. E., & Gadaleta, M. N. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.114 · Cited by 84
Self-citationAssociation of decreased mitochondrial DNA content with the progression of colorectal cancer
Cui, H.-H., Huang, P. C., Wang, Z., Zhang, Y., Zhang, Z., Xu, W., Wang, X., Han, Y., & Guo, X. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-110 · Cited by 84
BRCA-Associated Ovarian Cancer: From Molecular Genetics to Risk Management
Girolimetti, G., Perrone, A. M., Santini, D., Barbieri, E., Guerra, F., Ferrari, S., Zamagni, C., Iaco, P. D., Gasparre, G., & Turchetti, D. (2014) · BioMed Research International · doi:10.1155/2014/787143 · Cited by 83
Self-citationFath, M. A., Diers, A. R., Aykin‐Burns, N., Simons, A. L., Hua, L., & Spitz, D. R. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.13.8631 · Cited by 82
Mitochondrial DNA Rearrangements in Health and Disease-A Comprehensive Study
Damas, J., Samuels, D. C., Carneiro, J., Amorim, A., & Pereira, F. (2013) · Human Mutation · doi:10.1002/humu.22452 · Cited by 77
Liu, J., Wu, N., Ma, L., Liu, M., Liu, G., Zhang, Y., & Lin, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091606 · Cited by 77
“Metabolic Reprogramming” in Ovarian Cancer Cells Resistant to Cisplatin
Montopoli, M., Bellanda, M., Lonardoni, F., Ragazzi, E., Dorigo, P., Froldi, G., Mammi, S., & Caparrotta, L. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911794328501 · Cited by 76
Guha, M., Fang, J.-K., Monks, R., Birnbaum, M. J., & Avadhani, N. G. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-03-0192 · Cited by 66
Lee, W., Choi, H.-I., Kim, M. J., & Park, S. (2008) · Experimental & Molecular Medicine · doi:10.3858/emm.2008.40.1.109 · Cited by 65
Palorini, R., Simonetto, T., Cirulli, C., & Chiaradonna, F. (2013) · International Journal of Cell Biology · doi:10.1155/2013/243876 · Cited by 64
Mutations in the mitochondrial genome confer resistance of cancer cells to anticancer drugs
Mizutani, S., Miyato, Y., Shidara, Y., Asoh, S., Tokunaga, A., Tajiri, T., & Ohta, S. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01238.x · Cited by 64
Biswas, G., Anandatheerthavarada, H. K., & Avadhani, N. G. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401553 · Cited by 62
Consumption of oxygen: a mitochondrial-generated progression signal of advanced cancer
Cook, C. C., Kim, A. C., Terao, S., Gotoh, A., & Higuchi, M. (2012) · Cell Death and Disease · doi:10.1038/cddis.2011.141 · Cited by 62
Yang, H. (2011) · Oncology Letters · doi:10.3892/ol.2011.322 · Cited by 61
Regulation of Ca2+ signalling and Ca2+-mediated cell death by the transcriptional coactivator PGC-1α
Bianchi, K., Vandecasteele, G., Carli, C., Romagnoli, A., Szabadkai, G., & Rizzuto, R. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401784 · Cited by 60
Moro, L., Arbini, A., Marra, E., & Greco, M. (2008) · Analytical Cellular Pathology · doi:10.1155/2008/798134 · Cited by 60
Self-citationNomura, A., Dauer, P., Gupta, V. K., McGinn, O., Arora, N., Majumdar, K., Uhlrich, C., Dalluge, J. J., Dudeja, V., Saluja, A. K., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10838 · Cited by 58
Su, C., Chang, Y., Yang, C., Huang, M.-S., & Hsiao, M. (2016) · Scientific Reports · doi:10.1038/srep31357 · Cited by 58
Philley, J. V., Kannan, A., Qin, W., Sauter, E. R., Ikebe, M., Hertweck, K. L., Troyer, D. A., Semmes, O. J., & Dasgupta, S. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25240 · Cited by 54
Magda, D. J., Lecane, P. S., Prescott, J. E., Thiemann, P. A., Ma, X., Dranchak, P. K., TOLENO, D. M., Ramaswamy, K. A., Siegmund, K. D., & Hacia, J. G. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-521 · Cited by 53
An inherited mitochondrial DNA disruptive mutation shifts to homoplasmy in oncocytic tumor cells
Gasparre, G., Iommarini, L., Porcelli, A. M., Lang, M., Ferri, G. G., Kurelac, I., Zuntini, R., Mariani, E., Pennisi, L. F., Pasquini, E., et al. (2008) · Human Mutation · doi:10.1002/humu.20870 · Cited by 52
Amadori, D., Frassineti, G. L., Matteis, A. D., Mustacchi, G., Santoro, A., Cariello, S., Ferrari, M., Nascimben, O., Nanni, O., Lombardi, A., et al. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006063412726 · Cited by 52
MtDNA depleted PC3 cells exhibit Warburg effect and cancer stem cell features
Li, X., Zhong, Y., Lu, J., Axcrona, K., Eide, L., Syljuåsen, R. G., Peng, Q., Wang, J., Zhang, H., Goscinski, M. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9610 · Cited by 49
Koochekpour, S., Marlowe, T. A., Singh, K. K., Attwood, K. M., & Chandra, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074688 · Cited by 48
Xie, C., Jin, J., Bao, X., Zhan, W.-H., Han, T.-Y., Gan, M., Zhang, C., & Wang, J. (2016) · Oncotarget · doi:10.18632/oncotarget.6311 · Cited by 47
The Use of Mitochondria-Targeted Endonucleases to Manipulate mtDNA
Bacman, S. R., Williams, S. L., Pinto, M., & Moraes, C. T. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-801415-8.00018-7 · Cited by 46
Mitochondria in pluripotent stem cells: stemness regulators and disease targets
Folmes, C. D. L., Ma, H., Mitalipov, S. M., & Terzic, A. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.02.001 · Cited by 46
PGC-1β mediates adaptive chemoresistance associated with mitochondrial DNA mutations
Yao, Z., Jones, A. W. E., Fassone, E., Sweeney, M. G., Lebiedzińska, M., Suski, J. M., Wieckowski, M. R., Tajeddine, N., Hargreaves, I. P., Yasukawa, T., et al. (2012) · Oncogene · doi:10.1038/onc.2012.259 · Cited by 44
Gonzalez‐Sanchez, E., Marı́n, J. J. G., & Perez, M. J. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400732p · Cited by 44
mtCLIC is up‐regulated and maintains a mitochondrial membrane potential in mtDNA‐depleted L929 cells
Arnould, T., Mercy, L., Houbion, A., Vankoningsloo, S., Renard, P., Pascal, T. G., Ninane, N., Demazy, C., & Raes, M. J. (2003) · The FASEB Journal · doi:10.1096/fj.03-0075fje · Cited by 43
Engineered mtZFNs for Manipulation of Human Mitochondrial DNA Heteroplasmy
Gammage, P. A., Haute, L. V., & Minczuk, M. A. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3040-1_11 · Cited by 43
Arbini, A., Guerra, F., Gréco, M., Marra, E., Gandee, L., Xiao, G., Lotan, Y., Gasparre, G., Hsieh, J.-T., & Moro, L. (2013) · Oncogenesis · doi:10.1038/oncsis.2013.45 · Cited by 41
Self-citationKalsbeek, A. M. F., Chan, E. K. F., Grogan, J., Petersen, D. C., Jaratlerdsiri, W., Gupta, R., Lyons, R. J., Haynes, A., Horvath, L. G., Kench, J. G., et al. (2016) · Aging · doi:10.18632/aging.101044 · Cited by 38
Skp2 Overexpression Is Associated with Loss of BRCA2 Protein in Human Prostate Cancer
Arbini, A., Greco, M., Yao, J. L., Bourne, P. A., Marra, E., Hsieh, J., di Sant'Agnese, P. A., & Moro, L. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.050 · Cited by 36
Self-citationMediani, L., Gibellini, F., Bertacchini, J., Frasson, C., Bosco, R., Accordi, B., Basso, G., Bonora, M., Calabrò, M. L., Mattiolo, A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6315 · Cited by 35
The awakening of an advanced malignant cancer: An insult to the mitochondrial genome
Cook, C. C., & Higuchi, M. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.08.017 · Cited by 34
Late-onset encephalopathy associated with a C11777A mutation of mitochondrial DNA
Deschauer, M., Bamberg, C., Claus, D., Zierz, S., Turnbull, D. M., & Taylor, R. W. (2003) · Neurology · doi:10.1212/01.wnl.0000055869.99975.4b · Cited by 33
Nie, H., Chen, G., He, J., Zhang, F., Li, M., Wang, Q., Zhou, H., Lyu, J., & Bai, Y. (2015) · Mitochondrion · doi:10.1016/j.mito.2015.12.001 · Cited by 31
Ferramosca, A., Conte, A., Guerra, F., Felline, S., Rimoli, M. G., Mollo, E., Zara, V., & Terlizzi, A. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.04.028 · Cited by 30
Self-citationMitochondrial respiratory defects promote the Warburg effect and cancer progression
Srinivasan, S., Guha, M., & Avadhani, N. G. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1085120 · Cited by 23
Nath, K., NELSON, D. S., Heitjan, D. F., Zhou, R., Leeper, D. B., & Glickson, J. D. (2015) · NMR in Biomedicine · doi:10.1002/nbm.3260 · Cited by 20
Suzuki, S., Naito, A., Asano, T., Evans, T. T., Reddy, S. A. G., & Higuchi, M. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.020 · Cited by 19
Gene expressions associated with chemosensitivity in human hepatoma cells.
Hoshida, Y., Moriyama, M., Otsuka, M., Kato, N., Taniguchi, H., Shiratori, Y., Seki, N., & Omata, M. (2007) · PubMed · Cited by 17
Mitochondrial DNA 4977‐base pair common deletion in blood leukocytes and melanoma risk
Shen, J., Wan, J., Huff, C. D., Fang, S., Lee, J. E., & Zhao, H. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12474 · Cited by 8
Liu, Y., Wu, X., Li, X., Kvalheim, G., Axcrona, U., Axcrona, K., & Suo, Z. (2013) · Ultrastructural Pathology · doi:10.3109/01913123.2013.770112 · Cited by 3
Cited by
The role of m6A RNA methylation in cancer metabolism
An, Y., & Duan, H. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01500-4 · Cited by 871
The molecular mechanisms of chemoresistance in cancers
Zheng, H.-C. (2017) · Oncotarget · doi:10.18632/oncotarget.19048 · Cited by 624
Kleih, M., Böpple, K., Dong, M., Gaißler, A., Heine, S., Olayioye, M. A., Aulitzky, W. E., & Essmann, F. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2081-4 · Cited by 422
Lin, Z., Wu, Y., Xu, Y., Li, G., Li, Z., & Liu, T. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01650-5 · Cited by 297
Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management
Jin, P., Jiang, J., Zhou, L., Huang, Z., Nice, E. C., Huang, C., & Fu, L. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01313-4 · Cited by 273
Metadata
- Authors
- Guerra, F., Arbini, A. A., & Moro, L.
- Venue
- Biochimica et Biophysica Acta (BBA) - Bioenergetics
- Publisher
- Elsevier BV
- Published
- 2017-08
- Volume
- 1858
- Issue
- 8
- Pages
- 686-699
- ISSN
- 0005-2728 (ISSN-L)
- OpenAlex
- W2584378351
- Cited by
- 323
- References
- 151
- FWCI
- 11.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.